Skip to main content

Articles

Page 11 of 11

  1. Authors: Greatjoy Njabulo Mazibuko, Evans Sagwa, Harriet Rachel Kagoya, Dan Kibuule, Timothy Rennie, Tukai Mavere, Reem Ghoneim, David Mabirizi, Ester Naikaku, Qamar Niaz and Jennie Lates
    Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):P12

    This article is part of a Supplement: Volume 7 Supplement 1

  2. This study aimed to explore patients’ utilization of repeat prescriptions for antibiotics indicated in upper respiratory tract infections (URTI). An emphasis was placed on whether the current system of repeat ...

    Authors: Iman Zayegh, Theresa L Charrois, Jeffery Hughes and Kreshnik Hoti
    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:17
  3. Many low income countries struggle to provide safe and effective medicines due to poor public health care infrastructure, budgetary constraints, and lack of human resource capacity. Private sector pharmacies a...

    Authors: Catherine Birabwa, Jude Murison, Valerie Evans, Celestino Obua, Amon Agaba, Paul Waako and Allyson Pollock
    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:18
  4. Death among tuberculosis patients is one of the major reasons for non-attainment of 85% treatment success target set by World Health Organization. In this short paper, we evaluated whether the overall mortalit...

    Authors: Muhammad Atif, Syed Azhar Syed Sulaiman, Asrul Akmal Shafie, Muhammad Qamar Uz Zaman and Muhammad Asif
    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:16
  5. Adherence to treatment guidelines for uncomplicated malaria is critical to the success of malaria case management. Poor adherence has implications for increased malaria burden, in view of the risk of widesprea...

    Authors: Charles C Ezenduka, Mathew J Okonta and Charles O Esimone
    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:15
  6. To determine the incidence of symptomatic moderate-to-severe adverse events during treatment of drug-resistant tuberculosis, and to compare their risk and outcomes by patients’ human immunodeficiency virus (HI...

    Authors: Evans L Sagwa, Aukje K Mantel-Teeuwisse and Nunurai C Ruswa
    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:14
  7. The United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA), the main primary healthcare provider for 4.9 million Palestinian refugees, spent USD18.3 million on essential medicin...

    Authors: Margaret Ewen, Maisa Al Sakit, Rawan Saadeh, Richard Laing, Catherine Vialle-Valentin, Akihiro Seita and Joske Bunders
    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:13
  8. The rapid increase in drug expenditure has become a major source of public criticism in China. In 2009, the National Essential Medicine System (NEMS) was launched in China to control drug prices and improve ac...

    Authors: Yan Song, Ying Bian, Max Petzold, Lingui Li and Aitian Yin
    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:12
  9. A public-private partnership in Tanzania launched the accredited drug dispensing outlet (ADDO) program to improve access to quality medicines and pharmaceutical services in rural areas. ADDO dispensers play a ...

    Authors: Richard Valimba, Jafary Liana, Mohan P Joshi, Edmund Rutta, Martha Embrey, Maganga Bundala and Bryceson Kibassa
    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:11
  10. Do antimicrobial stewardship programs (ASPs) contribute to reduction of antimicrobial therapy costs in Japanese community hospitals? To answer this health economic question, a before-after comparative two-year...

    Authors: Tetsuya Fukuda, Hidemi Watanabe, Saeko Ido and Makoto Shiragami
    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:10
  11. The aim of this study was to investigate Jordanian physicians’ perception and attitudes toward generic medicines and generic substitution. It also aimed to examine factors that affect physicians’ pattern of pr...

    Authors: Faris El-Dahiyat, Reem Kayyali and Penelope Bidgood
    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:7
  12. Limited human resources are widely recognised as an impediment to achieving the health-related Millennium Development Goals in Pacific Island Countries, with the availability of medical supplies and suitably t...

    Authors: Andrew N Brown and Ben Gilbert
    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:5
  13. Regulation of the pharmaceutical system is a crucial, yet often neglected, component in ensuring access to safe and effective medicines. The aim of this study was to provide an in-depth analysis of the existin...

    Authors: Alessandra Ferrario, Nina Sautenkova, Zinaida Bezverhni, Rita Seicas, Jarno Habicht, Panos Kanavos and Vladimir Safta
    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:4
  14. Since 2004, the government of Tanzania has been rolling out antiretroviral treatment programs all over the country. However, the capacity of the health system to cope with the rapid scale-up of these programs ...

    Authors: Amani Thomas Mori and Joyce Owenya
    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:3
  15. The aims of the study were to examine the association between immigrant background and medicine use for headache and stomach-ache among adolescents, and whether symptoms of headache and stomach-ache could expl...

    Authors: Lourdes Cantarero-Arévalo, Bjørn E Holstein, Anette Andersen, Maria Kristiansen and Ebba H Hansen
    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:1
  16. Chloroquine (CQ), after 67 years of use in Haiti, is still part of the official treatment policy for malaria. Several countries around the world have used CQ in the past due to its low incidence of adverse eve...

    Authors: Michael E von Fricken, Thomas A Weppelmann, Jennifer D Hosford, Alexander Existe and Bernard A Okech
    Citation: Journal of Pharmaceutical Policy and Practice 2013 6:10
  17. Antibacterial drugs (hereafter referred to as antibiotics) are crucial to treat infections during delivery and postpartum period to reduce maternal mortality. Institutional deliveries have the potential to sav...

    Authors: Megha Sharma, Linda Sanneving, Kalpana Mahadik, Michele Santacatterina, Suryaprakash Dhaneria and Cecilia Stålsby Lundborg
    Citation: Journal of Pharmaceutical Policy and Practice 2013 6:9
  18. Continuous provision of appropriate medicines of assured quality, in adequate quantities, and at reasonable prices is a concern for all national governments. A national medicines policy (NMP) developed in a co...

    Authors: Joëlle M Hoebert, Liset van Dijk, Aukje K Mantel-Teeuwisse, Hubert GM Leufkens and Richard O Laing
    Citation: Journal of Pharmaceutical Policy and Practice 2013 6:5
  19. Bacterial meningitis is a medical emergency associated with high mortality rates. Cerebrospinal fluid (CSF) culture is the “gold standard” for diagnosis of meningitis and it is important to establish the susce...

    Authors: Assegid Mengistu, Johannes Gaeseb, Gottfried Uaaka, Christophine Ndjavera, Kennedy Kambyambya, Lazarus Indongo, Francis Kalemeera, Christopher Ntege, David Mabirizi, Mohan P Joshi and Evans Sagwa
    Citation: Journal of Pharmaceutical Policy and Practice 2013 6:4

Annual Journal Metrics